home / stock / tbio / tbio news


TBIO News and Press, Translate Bio Inc. From 05/15/23

Stock Information

Company Name: Translate Bio Inc.
Stock Symbol: TBIO
Market: NASDAQ
Website: codexdna.com

Menu

TBIO TBIO Quote TBIO Short TBIO News TBIO Articles TBIO Message Board
Get TBIO Alerts

News, Short Squeeze, Breakout and More Instantly...

TBIO - Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)

SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop automation solutions for DNA and mRNA synthesis at Protein Engineering Summit (PEGS Boston 2023) wh...

TBIO - ARS, Dermata top healthcare gainers; Heron, Assure among losers

2023-05-12 10:03:10 ET Gainers: ARS Pharmaceuticals ( SPRY ) +77% . Dermata Therapeutics ( DRMA ) +63% . AirSculpt Technologies ( AIRS ) +27% . GlycoMimetics ( GLYC ) +14% . BioAtla ( BCAB ) +13% . Losers: Heron Thera...

TBIO - Codex DNA GAAP EPS of -$0.37 in-line, revenue of $6.31M misses by $1.09M

2023-05-11 16:19:38 ET Codex DNA press release ( NASDAQ: TBIO ): Q1 GAAP EPS of -$0.37 in-line. Revenue of $6.31M (+12.1% Y/Y) misses by $1.09M . For further details see: Codex DNA GAAP EPS of -$0.37 in-line, revenue of $6.31M misses by $1.09M

TBIO - Telesis Bio Reports First Quarter 2023 Financial Results

-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the first quarte...

TBIO - Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023

SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter 2023 financial results on Thursday, May 11, 2023, after the market closes. In conjunction with the...

TBIO - Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® Select Ki t product line, releasing two novel kits to enable DNA amplification and scale-up. ...

TBIO - FATE, GRTS and KZR are among after hour movers

2023-03-28 17:27:17 ET Gainers: Arcturus Therapeutics ( ARCT ) +15% . lululemon athletica ( LULU ) +11% . Fate Therapeutics ( FATE ) +5% . Kezar Life Sciences ( KZR ) +5% . Longboard Pharmaceuticals ( LBPH ) +4% . Losers: ...

TBIO - Telesis Bio, Inc. (TBIO) Q4 2022 Earnings Call Transcript

2023-03-25 10:28:04 ET Telesis Bio, Inc. (TBIO) Q4 2022 Earnings Conference Call March 21, 2023, 16:30 ET Company Participants Jen Carroll - VP, IR Todd Nelson - President, CEO & Director Eric Esser - COO Conference Call Participants Brandon Couil...

TBIO - PYXS, CRSP, SCHL and SBUX are among after hour movers

2023-03-23 17:01:12 ET Gainers: Pyxis Oncology ( PYXS ) +15% . CRISPR Therapeutics ( CRSP ) +11% . ADMA Biologics ( ADMA ) +6% . Harrow Health ( HROW ) +4% . Solid Power ( SLDP ) +5% . Losers: Scholastic ( SCHL ) -1...

TBIO - LKCO, VIA and ADD among mid-day movers

2023-03-22 13:29:15 ET Gainers: GameStop ( GME ) +41% . Telesis Bio ( TBIO ) +31% . EZGO Technologies ( EZGO ) +33% . CorEnergy Infrastructure ( CORR ) +28% . 89bio ( ETNB ) +25% . JanOne ( JAN ) +27% . InMed Phar...

Previous 10 Next 10